773
Views
0
CrossRef citations to date
0
Altmetric
Oncology

Characterizing the real-world economic burden of metastatic castration-sensitive prostate cancer in the United States

, , , , , , & show all
Pages 381-391 | Received 10 Jan 2024, Accepted 23 Feb 2024, Published online: 11 Mar 2024

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.